Name | Value |
---|---|
Revenues | 2,041.0K |
Cost of Revenue | 1,436.0K |
Gross Profit | 605.0K |
Operating Expense | 4,334.0K |
Operating I/L | -3,729.0K |
Other Income/Expense | -2.0K |
Interest Income | 445.0K |
Pretax | -4,176.0K |
Income Tax Expense | 445.0K |
Net Income/Loss | -4,176.0K |
Avinger, Inc. is a medical device company specializing in image-guided and catheter-based systems for treating peripheral arterial disease (PAD). Its lumivascular platform integrates optical coherence tomography with interventional catheters, providing real-time intravascular imaging during PAD procedures. The company's products include Lightbox imaging consoles, Ocelot catheters for penetrating arterial blockages, Pantheris atherectomy device for plaque removal, and CTO-crossing catheters Wildcat and Kittycat 2. Avinger also develops IMAGE-BTK for below-the-knee PAD lesions. Its customers are interventional cardiologists, vascular surgeons, and interventional radiologists.